Example: Heart Attack

Search clinical trials for: Acarbose

Total 99 results

NCT04419337

Recruiting

Antidiabetic Triple Therapy Effects on Surrogate Tests After Stroke

Conditions: Diabetes Mellitus; Stroke
NCT04287387

Not yet recruiting

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

Conditions: Type2 Diabetes Mellitus
NCT04180813

Recruiting

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Conditions: Diabetes Mellitus, Type 2
NCT04065581

Completed

Bioequivalence Study for Acarbose/Metformin FDC

Conditions: Diabetes Mellitus, Type 2
NCT03961659

Recruiting

Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.

Conditions: Type 2 Diabetes Mellitus; Obesity; Cognitive Impairment
NCT03805191

Recruiting

A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients

Conditions: Type 2 Diabetes Mellitus; Poor Glycemic Control
NCT03794336

Recruiting

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive

Conditions: Type 2 Diabetes Mellitus
NCT03602638

Not yet recruiting

Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

Conditions: Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
NCT03492580

Completed

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

Conditions: Diabetes Mellitus, Type 2; Cardiovascular Diseases
NCT03383068

Unknown status

Research of Intensive Metabolic Intervention Before Pregnancy in PCOS

Conditions: PCOS; Impaired Glucose Tolerance
NCT03380546

Recruiting

Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.

Conditions: Gestational Diabetes Mellitus in Pregnancy
NCT03359837

Active, not recruiting

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy

Conditions: Type 2 Diabetes Mellitus
NCT03349684

Completed

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients

Conditions: Diabetes Mellitus, Type 2
NCT03344341

Terminated

A Phase IV Study in Drug-Naive Patients With T2DM in China

Conditions: Type 2 Diabetes Mellitus
NCT03241303

Completed

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

Conditions: Glucose Metabolism Disorders
NCT02999841

Unknown status

Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients

Conditions: Diabetes Mellitus, Type 2; Obesity
NCT02953093

Completed

Study of Acarbose in Longevity

Conditions: Aging
NCT02879955

Completed

Carbohydrates and Gut Hormones After Gastric Bypass Surgery

Conditions: Overweight
NCT02865499

Completed

Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)

Conditions: Aging
NCT02836704

Completed

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)

Conditions: Diabetes Mellitus, Type 2
NCT02685852

Completed

Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

Conditions: Hyperinsulinemic Hypoglycemia
NCT02605772

Unknown status

Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes

Conditions: Type 2 Diabetes Mellitus
NCT02589353

Recruiting

Human Oral Detection of Glucose Olygomers

Conditions: Healthy Volunteers
NCT02587741

Recruiting

Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens

Conditions: Diabetic Retinopathy
NCT02527993

Completed

Treatment of Hypoglycemia Following Gastric Bypass Surgery

Conditions: Hypoglycemia; Obesity; Surgery
NCT02500329

Unknown status

Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients

Conditions: Endothelial Function; Type 2 Diabetes; Gemigliptin; Acarbose
NCT02476760

Completed

Incretin-based Drugs and Acute Pancreatitis

Conditions: Diabetes Mellitus, Type 2
NCT02475499

Completed

Incretin-based Drugs and Pancreatic Cancer

Conditions: Diabetes Mellitus, Type 2
NCT02462369

Unknown status

Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients

Conditions: Microalbuminuria; Microalbuminuria /Creatinine Ratios ACR
NCT02456428

Completed

Incretin-based Drugs and the Risk of Heart Failure

Conditions: Type 2 Diabetes Mellitus
NCT02446834

Unknown status

Research of Intensive Lifestyle Intervention for PCOS Patients With IGT

Conditions: Polycystic Ovary Syndrome
NCT02438397

Unknown status

the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin

Conditions: Type 2 Diabetes
NCT02355509

Completed

Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

Conditions: Glucose Intolerance; Postprandial Hyperglycemia; Cardiovascular Risk Factor
NCT02315495

Completed

Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT02273050

Completed

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Conditions: Type 2 Diabetes Mellitus
NCT02243176

Completed

24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy

Conditions: Type 2 Diabetes Mellitus
NCT02211950

Completed

Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers

Conditions: Healthy
NCT02143765

Completed

Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT02072096

Terminated

A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

Conditions: Diabetes Mellitus, Type 2
NCT02049814

Completed

Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes

Conditions: Type 2 Diabetes Mellitus
NCT02043886

Completed

Acarbose, Postprandial Hypotension and Type 2 Diabetes

Conditions: Type 2 Diabetes; Postprandial Hypotension
NCT01961388

Withdrawn

Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy

Conditions: Diabetes Mellitus
NCT01915264

Withdrawn

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice

Conditions: Diabetes Mellitus, Type 2
NCT01914133

Unknown status

Acarbose and Older Adults With Postprandial Hypotension

Conditions: Other Specified Hypotension; Syncope
NCT01863147

Completed

Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

Conditions: Newly Diagnosed Type 2 Diabetes; Coronary Artery Disease
NCT01839344

Completed

Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.

Conditions: Diabetes Mellitus, Type 2
NCT01758471

Unknown status

Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT01728740

Completed

Bioequivalence Study for Acarbose / Metformin FDC

Conditions: Diabetes Mellitus, Type II
NCT01709305

Completed

A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)

Conditions: Type 2 Diabetes Mellitus
NCT01697592

Completed

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Conditions: Type 2 Diabetes Mellitus